Inforsense Ltd is a private company based in London, UK with additional offices in Cambridge, MA, USA and Shanghai, China. Founded in 1999, the company specializes in providing fast answers to complex questions in business, healthcare, and life science. Inforsense has gained recognition for its suite of highly agile, predictive, and visual enterprise business intelligence and reporting software.
The company's core expertise lies in the development of a generic, horizontal, high-performance business and scientific intelligence and web-based reporting platform. This platform enables organizations to integrate, automate, and visualize data sources, information, and analysis processes to deliver significantly improved productivity, performance, and breakthrough predictive insights.
Inforsense goes beyond traditional business intelligence by enabling predictive analytics from a variety of data and text sources to be embedded into any third-party application software or hardware and delivered to users entirely over the web. The company's last investment was a $10.00M Venture Round investment on 25 October 2006, with participation from investors including Elaia, Imperial Innovations, and Noble Fund Managers.
Inforsense operates in diverse industries, including analytics, biotechnology, enterprise software, and information technology. With its innovative technology and focus on predictive analytics, the company presents an enticing opportunity for potential investors seeking exposure to cutting-edge business intelligence and data analytics solutions.
